[Community acquired pneumonia in children: Treatment of complicated cases and risk patients. Consensus statement by the Spanish Society of Paediatric Infectious Diseases (SEIP) and the Spanish Society of Paediatric Chest Diseases (SENP)].

Abstract

The incidence of community-acquired pneumonia complications has increased during the last decade. According to the records from several countries, empyema and necrotizing pneumonia became more frequent during the last few years. The optimal therapeutic approach for such conditions is still controversial. Both pharmacological management (antimicrobials and fibrinolysis), and surgical management (pleural drainage and video-assisted thoracoscopic surgery), are the subject of continuous assessment. In this paper, the Spanish Society of Paediatric Infectious Diseases and the Spanish Society of Paediatric Chest Diseases have reviewed the available evidence. Consensus treatment guidelines are proposed for complications of community-acquired pneumonia in children, focusing on parapneumonic pleural effusion. Recommendations are also provided for the increasing population of patients with underlying diseases and immunosuppression.

• Authors: D Moreno-Pérez, A Andrés Martín, A Tagarro García, A Escribano Montaner, J Figuerola Mulet, J J García García, A Moreno-Galdó, C Rodrigo Gonzalo de Lliria, J Saavedra Lozano
• Journal: Anales de pediatria (Barcelona, Spain : 2003) (An Pediatr (Barc)) Vol. 83 Issue 3 Pg. 217.e1-11 (Sep 2015) ISSN: 1695-9531 [Electronic] Spain
• Vernacular Title: Neumonía adquirida en la comunidad: tratamiento de los casos complicados y en situaciones especiales. Documento de consenso de la Sociedad Española de Infectología Pediátrica (SEIP) y Sociedad Española de Neumología Pediátrica (SENP).
• PMID: 25617977 (Publication Type: Consensus Development Conference, Journal Article, Practice Guideline)
• Copyright: Copyright © 2014 Asociación Española de Pediatría. Published by Elsevier España, S.L.U. All rights reserved.

Topics

• Child
• Community-Acquired Infections (therapy)
• Humans
• Pneumonia, Bacterial (complications, therapy)
• Pneumonia, Viral (complications, therapy)
• Risk